Pharmafile - Sales and Marketing News
Health authorities in Ghana have shared that for the first time they have confirmed two fatal cases of the Marburg virus, a relative of the Ebola...
WHO and the Kenyan government have launched an emergency hub for public health risks in the country’s capital and largest city, Nairobi. This hub is...
The CEO of UKSHA has said that the number of people being admitted to hospital with COVID-19 is expected to rise further. Dame Jenny Harries has...
The FDA has placed a partial clinical hold on Sanofi’s Phase III BTK inhibitor trial, following reports of drug-induced liver damage in certain...
New research has found that weight/body mass index (BMI) policies introduced by NHS commissioning groups in England are associated with a decrease in...
BioCryst Pharmaceuticals have shared new 96-week data from the open-label global randomised Phase III Apex-2 trial, and an independent six month...
Telehealth abortion clinics have shared that they are still offering pills to people outside of their states, following the Supreme Court overturn of...
The National Medical Products Administration (NMPA) has approved the supplemental NDA for TYVYT (sintilimab injection) in combination with...
NHS patients in England, who have been waiting over two years for surgery are being offered hospital treatment in certain parts of the country.
The CHMP has recommended upadacitinib (RINVOQ® 15 mg, once daily) for approval, for the treatment of adults with active non-radiographic axial...